A randomised phase II study of doxorubicin combined with thalidomide versus doxorubicin alone for patients with unresectable hepatocellular carcinoma

Update Il y a 4 ans
Reference: ISRCTN53872240

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Not provided at time of registration


Inclusion criteria

  • Hepatocellular Cancer

Links